Related references
Note: Only part of the references are listed.Impact of Ramadan-focused diabetes education on hypoglycemia risk and metabolic control for patients with type 2 diabetes mellitus: A systematic review
Ayla M. Tourkmani et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis
Mo'ez Al-Islam' E. Faris et al.
BRITISH JOURNAL OF NUTRITION (2020)
Qualitative evaluation of A Safer Ramadan, a structured education programme that addresses the safer observance of Ramadan for Muslims with Type 2 diabetes
Natalie Darko et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial
Zheng Kang Lum et al.
ANNALS OF FAMILY MEDICINE (2020)
Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes
Muhammad Yakoob Ahmedani et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
The effect of Ramadan focused education on patients with type 2 diabetes: A systematic review and meta-analysis
Hoda Gad et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial
Rakesh Sahay et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above
Haitham A. Jahrami et al.
EUROPEAN JOURNAL OF NUTRITION (2020)
Use of SGLT2 inhibitors during Ramadan: An expert panel statement q
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Recent Evidence on the Impact of Ramadan Diurnal Intermittent Fasting, Mealtime, and Circadian Rhythm on Cardiometabolic Risk: A Review
Ahmed S. BaHammam et al.
FRONTIERS IN NUTRITION (2020)
Diabetic hypoglycaemia during Ramadan fasting: A trans-national observational real-world study
Salem A. Beshyah et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy
Alaaeldin M. K. Bashier et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS)
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Diabetes and Ramadan: A multicenter study in Algerian population
Rachid Malek et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
Mohamed M. Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM)
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Differential effects of gender and patient background diversity on the changes in metabolic and biophysical profiles in people with type-2 diabetes from different ethnicities who fast during Ramadan (H1439); a prospective study from Qatar
Zeinab Dabbous et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Attitude and safety of patients with diabetes observing the Ramadan fast
Ebtesam M. Ba-Essa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
Martin M. Grajower et al.
NUTRIENTS (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring
Nesreen Aldawi et al.
LIBYAN JOURNAL OF MEDICINE (2019)
Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes
Elamin Abdelgadir et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia
Ayla M. Tourkmani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Incidence of hypoglycemia and its risk factors among diabetics during Ramadan in Abha city, Aseer Region, KSA
Yahia Mater AlKhaldi et al.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)
Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan
Sueziani B. Zainudin et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2018)
Ramadan fasting alters food patterns, dietary diversity and body weight among Ghanaian adolescents
Zakari Ali et al.
NUTRITION JOURNAL (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article
Ayla M. Tourkmani et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2018)
Assessment of Ramadan Education and Knowledge Among Diabetic Patients
Mussa Hussain Almalki et al.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2018)
Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus
Lobna F. El Toony et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2018)
A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan
Mohammed Bshair et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2018)
Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
Mohamed Hassanein et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Clinical practice points for diabetes management during RAMADAN fast
Shaukat Sadikot et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents
Abdul Jabbar et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Diabetes and Ramadan: Practical guidelines
Mohamed Hassanein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia
W. J. Wan Seman et al.
DIABETES OBESITY & METABOLISM (2016)
Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial
S. T. Azar et al.
DIABETES OBESITY & METABOLISM (2016)
Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
Asma Deeb et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2016)
Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies
Shaun Wen Huey Lee et al.
MEDICINE (2016)
Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with type 2 diabetes
Ayla M. Tourkmani et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Adipose tissue glycogen accumulation is associated with obesity-linked inflammation in humans
Victoria Ceperuelo-Mallafre et al.
MOLECULAR METABOLISM (2016)
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
Mohamed Khattab et al.
DIABETES THERAPY (2016)
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
Mohamed Khattab et al.
DIABETES THERAPY (2016)
Complications and the time of diagnosis of diabetes mellitus in primary care
Daniel Nogueira Cortez et al.
ACTA PAULISTA DE ENFERMAGEM (2015)
Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: Insights from continuous glucose monitoring (CGM)
N. Lessan et al.
DIABETES & METABOLISM (2015)
Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach
Jean Claude Mbanya et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Diabetes telemonitoring reduces the risk of hypoglycaemia during Ramadan: a pilot randomized controlled study
J. Y. Lee et al.
DIABETIC MEDICINE (2015)
Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED)
S. M. Babineaux et al.
DIABETIC MEDICINE (2015)
Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study
N. Shehadeh et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Kamran M. A. Aziz
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2015)
Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan
Laura N. McEwen et al.
BMJ OPEN DIABETES RESEARCH & CARE (2015)
Recommendations for management of diabetes during Ramadan: update 2015
Mahmoud Ibrahim et al.
BMJ OPEN DIABETES RESEARCH & CARE (2015)
Safety and Efficacy of Liraglutide as an Add-On Therapy to Pre-Existing AntiDiabetic Regimens during Ramadan, A Prospective Observational Trial
Azza Abdulaziz Khalifa et al.
JOURNAL OF DIABETES & METABOLISM (2015)
Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
Rachel Bedenis et al.
DIABETES CARE (2014)
A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan
E. M. Brady et al.
DIABETES OBESITY & METABOLISM (2014)
Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study
Melanie Yee Lee Siaw et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan
Line P. Malha et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2014)
A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study
Mohamed Hassanein et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2014)
Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan
Muhammad Yakoob Ahmedani et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2014)
The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
M. Al-Arouj et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
Serge Halimi et al.
DIABETES THERAPY (2013)
Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Anja Schweizer et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2013)
Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan
Abhijit Shete et al.
WORLD JOURNAL OF DIABETES (2013)
Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study
S. R. Aravind et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Insulin Therapy and Hypoglycemia
Anthony L. McCall
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
The importance of hypoglycemia in diabetic patients
Gita Shafiee et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2012)
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study
Mohamed Hassanein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study
S. R. Aravind et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Glucose-Dependent Insulinotropic Polypeptide A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
Mikkel Christensen et al.
DIABETES (2011)
Ramadan fasting with diabetes: An interview study of inpatients' and general practitioners' attitudes in the South of France
B. Gaborit et al.
DIABETES & METABOLISM (2011)
The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
S. Al Sifri et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Recommendations for Management of Diabetes During Ramadan
Monira Al-Arouj et al.
DIABETES CARE (2010)
Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan
V. Bravis et al.
DIABETIC MEDICINE (2010)
Hypoglycemia in Type 1 Diabetes Mellitus
Philip E. Cryer
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan
E. Hui et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast
A. H. Zargar et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Fasting of Ramadan in peoples with diabetes in Benghazi, Libya: an exploratory study
Rafik Ramadan Elmehdawi et al.
LIBYAN JOURNAL OF MEDICINE (2010)
Management of people with diabetes wanting to fast during Ramadan
E. Hui et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan
Okan Bakiner et al.
ACTA DIABETOLOGICA (2009)
Adjusting the Basal Insulin Regimen of Patients With Type 1 Diabetes Mellitus Receiving Insulin Pump Therapy During the Ramadan Fast: A Case Series in Adolescents and Adults
Yousra M. A. Hawli et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2009)
Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan
I. Salti
DIABETIC MEDICINE (2009)
Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan
D. Devendra et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women
Boumediene Meghit Khaled et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2009)
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
Bo Ahren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?
M. M'Guil et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan
Abdallah Kobeissy et al.
CLINICAL THERAPEUTICS (2008)
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
Chantal Mathieu et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting
Mustafa Cesur et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Diabetes and Ramadan: Review of the literature
B. Benaji et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes
A Mari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A population-based study of diabetes and its characteristics during the fasting month of Ramadan 13 countries -: Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) Study
I Salti et al.
DIABETES CARE (2004)
The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan
R Sari et al.
ENDOCRINE RESEARCH (2004)
A comparison of insulin lispro Mix25™ and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan
V Mattoo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2003)
Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting
M Mafauzy
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes
PE Cryer
DIABETOLOGIA (2002)
Share Paper
